To access this element change to forms mode OFF
Grant Award View - GA203594
Integrating lipidomic, metabolomic and genomic studies to define causal...
GA ID:
GA203594
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
1-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$2,669,716.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Integrating lipidomic, metabolomic and genomic studies to define causal metabolic pathways in cardiometabolic disease: Delivering precision medicine solutions for Australia.
Purpose:
Our metabolism plays a central role in the development type 2 diabetes, cardiovascular disease, age related dementia and some cancers. We plan to use new technology (genomics and metabolomics) to understand how our genes and environment combine to influence our metabolism and our health. We will use this new information to develop new tests for risk assessment and early detection and develop new treatments to maintain health and to prevent, attenuate or treat these common metabolic diseases.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009965
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA